Introduction
============

*Streptomyces* species are important sources for commercially available antibiotics ([@B18]; [@B27]). The production of these antibiotics is typically specified by large gene clusters that usually include cluster-situated regulators (CSRs). In many cases, transcription of antibiotic biosynthetic gene clusters is under the direct regulation of CSRs, which are in turn controlled by a plethora of higher-level regulatory systems that respond to various environmental and physiological signals ([@B3]; [@B42]; [@B23]).

Milbemycins, a group of 16-membered macrolide antibiotics, were isolated from the culture broths of several *Streptomyces* species, including *Streptomyces hygroscopicus* subsp. *aureolacrimosus*, *Streptomyces thermoarchaensis*, and *Streptomyces bingchenggensis* ([@B32]; [@B50]). Similar to avermectins, milbemycins possess a lactone ring and are potent anthelmintic and insecticidal agents that are widely used in veterinary, agricultural, and medical fields ([@B35]; [@B7]; [@B12]). In particular, milbemycins have been used to control avermectin and organophosphorus pesticides-resistant mites, Liriomyza, aphidoidea, and aleyrodidae on more than two dozen plant species. Milbemectin, a mixture of milbemycin A3 and A4, shows high acaricidal activity and has been widely used against agricultural mites since 1990 ([@B29]). The semisynthetic derivative of milbemycin A3/A4, milbemycin oxime, has been used to treat pests against filarid and nematode ([@B35]; [@B7]). Moreover, other milbemycin A3/A4 derivatives, such as lepimectin and latidectin, have also been commercialized and widely used in agricultural field ([@B11]; [@B15]).

The species *S. bingchenggensis*, isolated in 2007 by our group, has been used for the industrial production of milbemycin ([@B9]; [@B47]). Given the importance of milbemycin A3/A4 and their derivatives, many efforts have been made to increase the titer of milbemycin. In *S. bingchenggensis*, a variety of mutagenic methods, including treatment with *N*-methyl-*N*′-nitro-*N*-nitrosoguanidine (NTG) ([@B46]), ultraviolet mutagenesis ([@B46]), as well as room temperature plasma (ARTP) mutations have been adopted to increase the titer of milbemycin A3/A4 ([@B45]). Moreover, *in silico*-based metabolic engineering strategies such as deletion of *milD* (encoding C5-O-methyltransferase) to remove undesired C5-O-methylmilbemycins and deletion of the nanchangmycin gene cluster, which putatively competes for the same precursors, such as malonyl-CoA and methylmalonyl-CoA, have been performed to enhance the production of milbemycin A3/A4 in *S. bingchenggensis* ([@B55]). However, a limited understanding of the transcriptional regulation of milbemycin production has impeded the efforts to further improve antibiotic titers via manipulation of regulatory genes. Identification and characterization of novel transcriptional regulators involved in milbemycin biosynthesis are essential for the elucidation of the underlying regulatory mechanism, which in turn will benefit the genetic engineering of *S. bingchenggensis* to generate new hyper-producer strains.

In 2010, the milbemycin biosynthesis gene cluster (*mil*) was identified from the genome of *S. bingchenggensis* ([@B47]). The *mil* cluster (*sbi_00726*--*sbi_00790*) comprised of 10 genes, including one regulatory gene (*milR*) and nine structural genes located in six operons (i.e., *milA2*-*C*, *milA4*-*E*, *milR*-*A3*, *milA1*-*D*, *milF*, and *orf1*), and a large (62 kb) insertion fragment between *milR* and *milA1* ([@B47]; [@B57]). *milR*, the only CSR gene in the *mil* cluster, encodes a large ATP-binding regulator of the LuxR (LAL) family. Previously, MilR was found to be essential for milbemycin production, and activates the expression of *milA4*-*E* and *milF* directly ([@B57]). However, the higher-level transcriptional regulators controlling *milR* expression and, thus, the detailed regulatory networks of milbemycin production, remain elusive.

In *Streptomyces*, antibiotic production is often regulated by low-molecular-weight compounds, such as γ-butyrolactone signals (GBLs), avenolides, and furans ([@B3]; [@B28]; [@B18]; [@B27]). GBLs, the largest group of these compounds, can elicit antibiotic biosynthesis at nanomolar concentrations by binding to cognate receptor proteins ([@B18]). They share a characteristic 2,3-disubstituted-γ-butyrolactone core but differ in the C2 side chains that determine signaling specificity ([@B36]). In the process of cell growth, a small increase in expression of the GBL synthase, leads to gradually accumulated GBLs, which in turn binds to the receptor protein and releases its interaction with target genes ([@B25]). To date, the well-studied GBL systems include A-factor-mediated ArpA/AfsA system in *Streptomyces griseus* ([@B13]), SCBs-mediated ScbR/ScbA system in *Streptomyces coelicolor* ([@B6]), VBs-mediated BarA/BarX system in *Streptomyces virginiae* ([@B16]), IM-2-mediated FarA/FarX system in *Streptomyces lavendulae* ([@B43]), and SVB1-mediated JadR3/JadW1 system in *Streptomyces venezuelae* ([@B59]). Given the large number of more than 900 *Streptomyces* species described and the very few GBL-mediated ArpA/AfsA-like systems known, further research on the ArpA/AfsA-like regulatory cascades is required ([@B27]).

In this report, we describe a putative ArpA/AfsA-like system, SBI_08928/SBI_08929, which is designated as SbbR/SbbA in *S. bingchenggensis.* SbbR is a homolog of GBL receptors, while SbbA resembles proteins involved in the production of GBL signals. We demonstrate that the SbbR/SbbA system plays an important role in the production of milbemycin. SbbR controls milbemycin production by directly activating the transcription of *milR*, while SbbA appears to have a repressive effect on milbemycin production; both SbbR and SbbA have positive effects on cell growth. Interestingly, SbbR is also a pleiotropic regulator that controls the transcription of other CSR genes and global regulatory genes. This work deepens our understanding of an upper-level of regulation in milbemycin biosynthesis, and provides an effective approach to improve milbemycin production via genetic manipulation of SbbR/SbbA system in *S. bingchenggensis*.

Materials and Methods {#s1}
=====================

Bacterial Strains, Plasmids, Primers, and Growth Conditions
-----------------------------------------------------------

Bacterial strains and plasmids used in this study are summarized in **Table [1](#T1){ref-type="table"}**; primers are listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. *S. bingchenggensis* BC04, the producer of milbemycin A3/A4, is derived from *S. bingchenggensis* CGMCC 1734 which is deposited at China General Microbiological Culture Collection (CGMCC). *S. bingchenggensis* BC04 and its derivatives were grown at 28°C on SKYM (0.4% sucrose, 0.1% skimmed milk powder, 0.2% yeast extract, and 0.5% malt extract pH 7.2) agar for spore collection. Besides, SKYM medium together with minimal medium (MM) (0.1% [L]{.smallcaps}-asparagine, 0.1% K~2~HPO~4~, 0.04% MgSO~4~⋅7H~2~O, 0.002% FeSO~4~⋅7H~2~O, 2% glucose, and 2% agar) was used to analyze morphological differentiation. The media and methods used for milbemycin production were the same as previously reported ([@B57]).

###### 

Strains and plasmids used in this study.

  Strain or plasmid                   Description                                                                                                               Source or reference
  ----------------------------------- ------------------------------------------------------------------------------------------------------------------------- ---------------------
  ***S. bingchenggensis* strains**                                                                                                                              
  BC04                                Parental strain; milbemycin producer                                                                                      Laboratory stock
  ΔsbbR                               *sbbR* deletion mutant                                                                                                    This study
  ΔsbbR/sbbR                          ΔsbbR with the complementation vector pSET152::*sbbR*                                                                     This study
  ΔsbbA                               *sbbA* deletion mutant                                                                                                    This study
  ΔsbbA/sbbA                          ΔsbbA with the complementation vector pSET152::*sbbR*                                                                     This study
  BC04/pSET152                        Parental strain carrying empty vector pSET152                                                                             This study
  ***E. coli* strains**                                                                                                                                         
  JM109                               Host strain for cloning                                                                                                   Novagen
  ET12567(pUZ8002)                    ET12567 containing the non-transmissible RP4 derivative plasmid pUZ8002                                                   [@B14]
  BL21 (DE3)                          Host for protein expression                                                                                               Novagen
  DH5α                                Host for GFP reporter system                                                                                              Novagen
  **Plasmids**                                                                                                                                                  
  pBluescript (KS+)                   Routine DNA cloning and subcloning vector                                                                                 Novagen
  pUC119::*neo*                       Obtaining kanamycin resistance gene (*neo*)                                                                               [@B56]
  pKC1139                             *E. coli*-*Streptomyces* shuttle vector                                                                                   [@B4]
  pSET152                             Integrative *E. coli*-*Streptomyces* shuttle vector                                                                       [@B19]
  pET-23b (+)                         Vector for His-tagged protein expression in *E. coli*                                                                     Novagen
  pKC1139::Δ*sbbR::neo*               *sbbR* deletion vector based on pKC1139                                                                                   This study
  pSET152::*sbbR*                     *sbbR* complemented vector based on pSET152                                                                               This study
  pKC1139::Δ*sbbA::neo*               *sbbA* deletion vector based on pKC1139                                                                                   This study
  pSET152::*sbbA*                     *sbbA* complemented vector based on pSET152                                                                               This study
  pET23b::*sbbR*                      *sbbR* expression vector based on pET23b                                                                                  This study
  pBmilR                              A 413-bp DNA fragment containing SbbR binding region with the intact conserved site was inserted into pBluescript (KS+)   This study
  pBsbbA                              A 413-bp DNA fragment containing SbbR binding region with the intact conserved site was inserted into pBluescript (KS+)   This study
  mupBmilR                            A plasmid containing mutated conserved site amplified by PCR from pBmilR using primers mupmilR-F                          This study
  mupBsbbA                            A plasmid containing mutated conserved site amplified by PCR from pBmilR using primers mupsbbA-F                          This study
  pSET152::P*~milR~gfp*               pSET152 derivative; containing P*~milR~*-driven *gfp*                                                                     This study
  pSET152::P*~sbbA~gfp*               pSET152 derivative; containing P*~sbbA~*-driven *gfp*                                                                     This study
  pSET152::P*~milR~gfp*::SF14*sbbR*   pSET152::P*~milR~gfp* derivative; containing PSF14-driven *sbbR*                                                          This study
  pSET152::P*~sbbA~gfp*::SF14*sbbR*   pSET152::P*~sbbA~gfp* derivative; containing PSF14-driven *sbbR*                                                          This study
                                                                                                                                                                

Construction of the Phylogenetic Tree
-------------------------------------

The amino acid sequences of SbbR with its 36 homologs were individually aligned with multiple sequences obtained from the GenBank/EMBL/DDBJ databases using CLUSTAL X 1.83 software. The phylogenetic tree was reconstructed with the neighbor-joining algorithms ([@B33]) using MEGA software version 6.06 ([@B39]). Phylogenetic distances were calculated with the Jones-Taylor-Thornton (JTT) model ([@B44]). The stability of the clades in the trees was appraised using a bootstrap procedure with 1000 repeats ([@B8]). All positions containing gaps and missing data were eliminated from the dataset (complete deletion option).

Construction of *sbbR* and *sbbA* Disruption Mutants and Their Complementation
------------------------------------------------------------------------------

The *sbbR* and *sbbA* gene disruption were performed by the method of homologous recombination. To construct the *sbbR* disruption mutant, two fragments (sbbR-L: 1.9 kb, sbbR-R: 2.0 kb) flanking *sbbR* were amplified with the *S. bingchenggensis* BC04 genomic DNA as template by polymerase chain reaction (PCR) using the primer pairs sbbRLF/R and sbbRRF/R (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). The fragment sbbR-L was cut with *Hin*dIII and *Xba*I, and the fragment sbbR-R was cut with *Kpn*I and *Eco*RI. The plasmid pUC119::*neo* was used to obtain the kanamycin-resistance gene (*neo*) after *Hin*dIII and *Kpn*I digestion. The three resultant DNA segments were ligated into the sites of *Eco*RI and *Hin*dIII in pKC1139 to give pKC1139::*sbbR::neo*, in which a 519-bp fragment of *sbbR* was replaced by *neo*. pKC1139*::sbbR::neo* was subsequently introduced into *S. bingchenggensis* BC04 via conjugation ([@B14]). The exconjugants were selected on MS agar containing apramycin ([@B1]). After incubation on SKYM solid medium at 37°C for 9 days, double cross-over recombinant strains were obtained by selection for kanamycin-resistant (Kan^R^) and apramycin-sensitive (Apr^S^) clones. The obtained *sbbR* disrupted strain, designated as ΔsbbR, was confirmed by PCR using primer VsbbR-F and VsbbR-R followed by DNA sequencing.

Complementation was performed with pSET152 carrying *sbbR* expressed from its own promoter. The primers CsbbR-F and CsbbR-R were used to amplify the 1301-bp DNA fragment containing the *sbbR* ORF and its upstream region from genomic DNA of BC04 (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). The obtained DNA fragment was inserted into *Eco*RI and *Xba*I sites of pSET152 to create *sbbR* complementation vector pSET152::*sbbR*, which was introduced into ΔsbbR by intergenic conjugation to obtain the complemented strain ΔsbbR/sbbR ([@B19]).

To construct a *sbbA* deletion mutant, two fragments (sbbA-L: 1.5 kb and sbbA-R: 2.0 kb) flanking *sbbA* were amplified by primers sbbALF/R and sbbARF/R using the genomic DNA of BC04 as template, respectively. The fragment sbbA-L was digested with *Hin*dIII/*Xba*I, while the sbbA-R fragment was digested with *Kpn*I/*Eco*RI. These two fragments together with *neo* digested with *Hin*dIII/*Kpn*I were inserted into the site of *Eco*RI and *Hin*dIII in pKC1139 to generate pKC1139::*sbbA::neo*, in which a 385-bp fragment of *sbbA* was replaced by *neo*. The *sbbA* mutants were obtained with the same method as described previously, and were confirmed by PCR with VsbbA-F and VsbbA-R as primers, followed by DNA sequencing. The *sbbA* disruption mutant was designated as ΔsbbA.

For complementation of ΔsbbA, a 1643-bp fragment containing the intact *sbbA* ORF and its putative promoter region was amplified by PCR using primers CsbbA-F and CsbbA-R. The *Xba*I-*Eco*RV digested DNA fragment was ligated into pSET152 to give the *sbbA* complementation vector pSET152::*sbbA*, which was introduced into ΔsbbR by conjugation to obtain the complemented strain ΔsbbA/sbbA.

The plasmid pSET152 was introduced into BC04 to generate control strain BC04/pSET152.

HPLC Analysis of Milbemycin A3/A4
---------------------------------

Milbemycin A3/A4 was analyzed by the method previously reported ([@B57]). HPLC was performed by Agilent 1100 HPLC (Zorbax, SB-C18 column, 4.6 mm × 250 mm, 5 μm) at a flow rate of 1.0 ml/min with gradient from 0 to 100% of solvent B in 15 min (Solvent A: CH~3~CN:H~2~O:CH~3~OH = 7:1:2, v/v/v; Solvent B: CH~3~OH) and detected at 242 nm.

Overexpression and Purification of SbbR-His~6~ Protein
------------------------------------------------------

To prepare the SbbR-His~6~ protein, primers proSbbR-F and proSbbR-R were used to amplify the *sbbR* gene (the stop codon was excluded) with the BC04 genomic DNA. The amplified PCR products were digested with *Nde*I/*Xho*I and cloned between the *Nde*I/*Xho*I sites of pET23b (+) to generate the overexpression plasmid pET23b::*sbbR*, which was verified by nucleotide sequencing and then introduced into *E. coli* BL21 (DE3) for protein expression. IPTG (final concentration 0.1 mM) was used to induce SbbR-His~6~ expression. The nickel-nitrilotriacetic acid (Ni-NTA) agarose chromatography was used to purify the SbbR-His~6~ based on the protocol of the manufacturer (Novagen). The Amicon Ultra 0.5-ml centrifugal filters (Millipore membrane, 3 kDa cut-off size) (Millipore) were used to concentrate the protein based on the protocol provided by the manufacturer. Concentration of the total recovered protein was determined by BCA protein assay Kit (Novagen) with a standard of Bovine Serum Albumin (BSA). The purified protein was stored in 5% glycerol at -70°C.

Electrophoretic Mobility Shift Assays (EMSAs)
---------------------------------------------

Electrophoresis mobility shift assays were carried out as described previously ([@B49]; [@B22]). In brief, two fragments \[P*~milR~* (413-bp) and P*~R-A~* (464-bp)\] corresponding to the upstream region of *milR* and the intergenic region of *sbbR* and *sbbA* were generated by PCR from the genomic DNA of *S. bingchenggensis* BC04 with primer pairs pmilR-F/R and psbbR-A-F/R, respectively. Primers phrdB-F and phrdB-R were used to amplify the control probe P*~hrdB~* (443-bp). The other 79 primer pairs used to amplify promoter region probes are listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. The DNA probe (10 ng) was incubated with various concentrations of SbbR-His~6~ in 20 μl reaction mixture containing 20 mM Tris base, 2 mM dithiothreitol (DTT), 5 mM MgCl~2~, 0.5 μg calf BSA, and 5% (v/v) glycerol, 500 ng poly\[d(I-C)\] was added when necessary. After incubation at 25°C for 25 min, DNA-protein complexes and free DNA were separated by electrophoresis on non-denaturing 4% (wt/vol) polyacrylamide gel at 4°C with 0.5× TBE as the running buffer. After electrophoresis, DNA in the gel was stained with SYBR Gold nucleic acid gel stain for 30 min in 1.0× TBE and photographed under ultraviolet transillumination using Quantity One.

DNase I Footprinting
--------------------

In order to determine the binding sites of SbbR on P*~milR~* and P*~R-A~*, DNase I footprinting assays were carried out as described previously ([@B22]). DNA probes were prepared by PCR using 5′ FAM fluorescence-labeled primers listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. After being purified from agarose gel, labeled DNA probe (200 ng) and protein with different concentrations of SbbR-His~6~ were added to a final reaction volume of 50 μl, and incubated for 25 min at 25°C. DNase I (Promega) digestions were carried out for 75 s at 25°C and stopped with 20 mM EGTA. After ethanol extraction and precipitation, the purified samples were loaded in an Applied Biosystems 3730 DNA genetic analyzer together with the internal-lane size standard ROX-500 (Applied Biosystems). The dye primer-based sequencing kit (Thermo) was used to further precisely determine the sequences after aligning the capillary electrophoresis results of reactions. The results were then processed with GeneMarker v2.2.0 software.

Site-Directed Mutagenesis of SbbR Binding Sequences
---------------------------------------------------

To assess the specificity of SbbR on its binding sequence, site-directed mutagenesis was performed. Two fragments P*~milR~* and P*~R-A~* were ligated into the *Eco*RV-digested plasmid pBluescript KS (+) to generate plasmids pBmilR and pBsbbA, respectively. A fragment containing mutated P*~milR~* was amplified by primer pair mupmilR-F/R using the plasmid pBmilR as template. Similarly, the fragment containing mutated P*~R-A~* was amplified by primer pair mupsbbA-F/R using pBsbbA as template. These two fragments were self-ligated, generating mutant plasmids mupBmilR and mupBsbbA, respectively. The mutated sequences at the binding sites were further verified by DNA sequencing. Then mupBmilR and mupBsbbA were digested with *Hin*dIII/*Bam*HI to generate mutant probes P*~milR~*^∗^ and P*~R-A~*^∗^, respectively. The binding activity of SbbR-His~6~ to these probes was subsequently determined by EMSAs.

RNA Isolation and Quantitative Real-Time PCR
--------------------------------------------

Transcription levels of genes were compared between *S. bingchenggensis* BC04 and ΔsbbR by quantitative real-time PCR (qRT-PCR) analysis. For this purpose, total RNAs were isolated from cultures of *S. bingchenggensis* BC04 grown at 28°C at various time points (1, 2, 3, 5, and 9 days). RNA extraction was performed as described previously ([@B56]). The RNA sample was treated with RQ1 RNase-free DNase I (Promega) to remove genomic DNA. UV spectroscopy and agarose gel electrophoresis were used to examine the RNA quality and quantity. Synthesis of cDNA and subsequent qRT-PCR were essentially the same as described previously ([@B56]).

Determination of Transcriptional Start Points of *milR, sbbR*, and *sbbA*
-------------------------------------------------------------------------

The transcriptional start points (tsp) of *milR*, *sbbR* and *sbbA* were determined by using a 5′ RLM-RACE Kit (Thermo) according to the manufacturer's instructions. Briefly, total RNAs were prepared from a 3 days culture of *S. bingchenggensis* BC04 (for *milR* and *sbbR*) and a 2 days culture of ΔsbbR (for *sbbA*). First, total RNAs (10 μg) were successively treated with Calf Intestinal Alkaline Phosphatase (CIAP) and tobacco acid pyrophosphatase (TAP) and ligated with the 5′ RLM-RACE adapter using T4 RNA ligase. Reverse transcription was preceded by using M-MLV Reverse Transcriptase with random decamers supplied. A first round of PCR was performed with the cDNAs derived from RT Reactions using 5′ RLM-RACE outer primer and another gene specific-primer listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. To obtain a single specific band, a second round of PCR was performed with the original PCR product (25-fold dilution) as template, by using 5′ RLM-RACE inner primer and another nested primer listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. The final PCR product was inserted into pBluescript (KS+) and sent for sequencing.

GFP Reporter Assay in *E. coli*
-------------------------------

For construction of the reporter plasmid, the original plasmid pSET152 was cut with *Bam*HI and *Xba*I, and the promoters P*~milR~* and P*~sbbA~* were amplified with two primer pairs pmilRGFP-F/R and psbbAGFP-F/R, respectively. The green fluorescence gene (*gfp*) was amplified with primers GFP-F and GFP-R from pTAC ([@B51]). Prior to PCR amplification, primers pmilRGFP-R, psbbAGFP-R, and GFP-F were phosphorylated with T4 polynucleotide kinase to facilitate subsequent ligation reactions. P*~milR~* and P*~sbbA~* were digested with *Bam*HI and the *gfp* coding region was digested with *Xba*I. The P*~milR~* and P*~sbbA~* promoters and the *gfp* coding region were ligated into pSET152 which was cut with *Bam*HI/*Xba*I in a three-piece ligation reaction to generate pSET152::P*~milR~gfp* and pSET152::P*~sbbA~gfp*, respectively. To evaluate the regulatory effects of SbbR on P*~milR~* and P*~sbbA~* promoters, the strong constitutive promoter SF14 and the coding region of *sbbR* were amplified from plasmid pGusTSF14 and genomic DNA of BC04 with primers pSF14-F/pSF14-R and psbbRGFP-F/psbbRGFP-R, respectively ([@B51]). The plasmids pSET152::P*~milR~gfp* and pSET152::P*~sbbA~gfp* were digested with *Nhe*I and assembled with the SF14 promoter and the *sbbR* coding region to obtain the corresponding reporter plasmids pSET152::P*~milR~gfp*::SF14*sbbR* and pSET152::P*~sbbA~gfp*::SF14*sbbR*, respectively, which include, both SF14 promoter controlled *sbbR* and a *gfp* controlled by P*~milR~* or P*~sbbA~*, respectively. *sbbR* and *gfp* were placed in opposite orientations. These four plasmids together with the empty vector pSET152, which was used as a control, were each transferred to DH5α to detect green fluorescence (excitation at 485 nm; emission at 535 nm, Synergy H4 Multi-Mode Reader). All fluorescence values were normalized to growth rates (OD~600~). The average and standard deviation of three experimental replicates are presented by each value and error bar, respectively.

Preparation of GBL Crude Extracts
---------------------------------

The procedure used for preparation of GBL crude extracts was as described previously with slight modification ([@B18]; [@B59]). A total of 100 ml culture broth of BC04 or ΔsbbA grown in seed medium for 2 days was extracted with an equal volume of ethyl acetate. The organic phase was dried in a vacuum evaporator and re-dissolved in 1 ml DMSO.

Determination of Cell Dry Weight
--------------------------------

Two-milliliter cell cultures were collected by vacuum filtration and dried at 55°C to a constant weight.

Statistical Analysis
--------------------

All experiments mentioned above were carried out at least three times, independently. The mean values were presented as ± SD (standard deviation). The Student's *t*-test was used to analyze the data. *P* \< 0.05 is used as a standard criterion of statistical significance.

Results
=======

Identification of the ArpA/AfsA System SbbR/SbbA in *S. bingchenggensis*
------------------------------------------------------------------------

Genome analysis of *S. bingchenggensis* revealed an *arpA*/*afsA*-type system, *sbbR*/*sbbA* (*sbi_08928*/*sbi_08929*), which is ∼10^4^ kb far downstream of the *mil* cluster (*sbi_00726*--*sbi_00790*) (**Figure [1A](#F1){ref-type="fig"}**). An accurate prediction of open reading frame (ORF) is important for the study of gene function. After careful examination, we did not find a putative ribosome binding site (RBS) in the upstream region of the annotated *sbbR* or *sbbA* translation start codon; therefore, we re-annotated the coding sequences of *sbbR* and *sbbA*. The true *sbbR* coding region may span from nucleotide (nt) 10567682 to 10567062 on the reverse strand of the *S. bingchenggensis* chromosome consisting of 621 nucleotides, and *sbbA*'s real ORF may span from nt 10567842 to 10568729 on the forward strand of the chromosome consisting of 888 nucleotides.

![Bioinformatic analysis of SbbR in *S. bingchenggensis* BC04. **(A)** Schematic representation of the relative positions of *sbbR*, *sbbA*, and the *mil* cluster. Each arrow indicates a separate open reading frame (ORF) and orientation of transcription. **(B)** Phylogenetic analyses of SbbR and its homologs. SbbR of *S. bingchenggensis* BC04 is highlighted in bold. The CLUSTALW program was used for performing sequence alignment. The phylogenetic tree was constructed by applying the neighbor-joining algorithm. Bootstrap values \>50% (based on 1000 replications) are shown at branch points. Bar, 0.02 substitutions per amino acid position for the phylogenetic tree of SbbR.](fmicb-09-01064-g001){#F1}

*sbbR* encodes a TetR (Tetracycline Repressor) family regulator that shows similarity to GBL receptors such as Gbr from *Streptomyces tacrolimicus* (53% identity) ([@B34]), AvaR1 from *Streptomyces avermitilis* (31% identity) ([@B18]), and JadR3 from *S. venezuelae* (30% identity) ([@B59]). *sbbA*, which is located upstream of the oppositely oriented *sbbR* gene, encodes a putative GBL biosynthesis protein that shows 32% identity with FarX from *S. lavendulae* ([@B43]), 31% identity with SrrX from *Streptomyces rochei* ([@B2]), 27% identity with AfsA from *S. griseus* ([@B13]), and 25% identity with JadW1 from *S. venezuelae* ([@B59]). Previously, [@B26] constructed a phylogenetic tree for the GBL receptor homologs. These homologs were classified into two groups; one consists of canonical or "true" GBL receptors that bind GBLs as ligands, whereas the others are "pseudo" GBL receptors that do not bind GBLs. To get an indication of SbbR function, we reconstructed the phylogenetic tree for SbbR homologs. Phylogenetic analysis showed that SbbR belongs to the group of "true" GBL receptors represented by BarA ([@B16]), ArpA ([@B13]), and FarA ([@B43]) (**Figure [1B](#F1){ref-type="fig"}**). Furthermore, true GBL receptors and "pseudo" GBL receptors can be distinguished by their p*I* values: the true receptors appear to have acidic or neutral p*I* values, while the "pseudo" ones show basic p*I* values ([@B17]). As SbbR has a p*I* value of 5.81, we hypothesize it belongs to the group of true GBL receptors, but this requires further experimental confirmation. In screening of the whole genome of *S. bingchenggensis*, no other homologs of SbbR or SbbA were discovered. This indicates that there is likely only one ArpA/AfsA-type system present in *S. bingchenggensis.*

Effects of *sbbR* and *sbbA* Disruption on Phenotype and Milbemycin Production
------------------------------------------------------------------------------

To determine the roles of SbbR and SbbA in morphological differentiation and milbemycin production, *sbbR* and *sbbA* were disrupted individually. In ΔsbbR, a 519-bp fragment internal to *sbbR* ORF, containing the complete coding region of the HTH-type DNA-binding motif (a.a. 12--58) essential for TetR function, was replaced by a kanamycin resistance gene *neo* via homologous recombination (Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}). Similarly, the *sbbA* deletion mutant ΔsbbA was constructed with a 385-bp fragment covering much of the A-factor biosynthesis hotdog domain (a.a. 21--159) of *sbbA* replaced by *neo* (Supplementary Figure [S1B](#SM1){ref-type="supplementary-material"}). The resulting mutants ΔsbbR and ΔsbbA were confirmed by PCR (Supplementary Figures [S1C,D](#SM1){ref-type="supplementary-material"}) and DNA sequencing (data not shown).

Compared with the parental strain *S. bingchenggensis* BC04 and BC04/pSET152 controls, ΔsbbR formed spores earlier and the spores were darker pigmented on SKYM (a rich medium for sporulation) and MM; while on MM, ΔsbbR presented an obvious weak growth of aerial mycelium (**Figure [2A](#F2){ref-type="fig"}**). ΔsbbA grew a little sparse but sporulated normally on these two media (**Figure [2A](#F2){ref-type="fig"}**). In complementation experiments, pSET152::*sbbR* was introduced into ΔsbbR to generate ΔsbbR/sbbR and pSET152::*sbbA* was transferred to ΔsbbA to generate ΔsbbA/sbbA. As expected, the complementation strains gave full complementation (**Figure [2A](#F2){ref-type="fig"}**). These results suggested that *sbbR* and *sbbA* are involved in the regulation of morphological development.

![Effects of *sbbR* and *sbbA* on sporulation, milbemycin production, and cell growth. **(A)** Effects of *sbbR* and *sbbA* deletion on morphological differentiation. **(B)** Comparative milbemycin A3/A4 production in BC04, BC04/pSET152, ΔsbbR, ΔsbbR/sbbR, ΔsbbA, and ΔsbbA/sbbA cultured in fermentation medium. **(C)** Quantitative milbemycin A3/A4 production of BC04, ΔsbbR, and ΔsbbA cultured in fermentation medium. **(D)** Growth curves of BC04, ΔsbbR, and ΔsbbA strains cultured in fermentation medium. Biomass is expressed as dry cell weight. **(E)** Milbemycin A3/A4 yield per g dry cell weight of BC04, ΔsbbR, and ΔsbbA strains. Data are presented as the averages of the results of three independent experiments. Error bars show standard deviations.](fmicb-09-01064-g002){#F2}

In comparison with the parental strain *S. bingchenggensis* BC04, production of milbemycin A3/A4 in ΔsbbR was significantly reduced (**Figure [2B](#F2){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}); whereas the titer of milbemycin A3/A4 in ΔsbbA was increased (**Figure [2B](#F2){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). To verify that the opposite phenotypic changes were due to the separate disruption of *sbbR* and *sbbA*, complementation strains ΔsbbR/sbbR and ΔsbbA/sbbA were also tested for milbemycin production. The results showed that ΔsbbR/sbbR and ΔsbbA/sbbA produced similar levels of milbemycin A3/A4 as those of BC04 and BC04/pSET152 controls, indicating that SbbR is an activator of milbemycin production and SbbA has a repressive effect on milbemycin production (**Figure [2B](#F2){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Next, milbemycin production (**Figure [2C](#F2){ref-type="fig"}**), the cell growth (**Figure [2D](#F2){ref-type="fig"}**), and milbemycin yield per gram dry cell weight (**Figure [2E](#F2){ref-type="fig"}**) of ΔsbbR, ΔsbbA and the parental strain BC04 were quantitatively compared in fermentation medium. Compared with the parental strain BC04, deletion of *sbbR* decreased milbemycin production dramatically by 80% (from 2537 to 514 mg/l) and reduced cell growth; the disruption of *sbbA* increased milbemycin production by 25% (from 2537 to 3169 mg/l) but reduced biomass accumulation throughout the entire time-course (**Figures [2C,D](#F2){ref-type="fig"}**). These data revealed that *sbbR* plays a positive regulatory role in milbemycin production and cell growth; meanwhile, *sbbA* plays a negative role in milbemycin production and is also important for cell growth.

SbbR Binds to the Upstream Regions of *milR, sbbR*, and *sbbA*
--------------------------------------------------------------

To assess whether the SbbR/SbbA system directly regulates milbemycin biosynthesis, the ArpA-like protein SbbR was expressed as a C-terminally His~6~-tagged protein and tested in EMSAs with all potential promoter regions in the *mil* cluster, including the putative promoters of *milA2*, *milA4*, *milE*, *orf1*, *milF*, *milR*, *milA3*, and *milA1* (**Figure [3A](#F3){ref-type="fig"}** and Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). The intergenic region of *sbbR*-*sbbA* (P*~R-A~*) was also included for EMSA, because *sbbR* and *sbbA* are adjacent on the chromosome, transcribed divergently, and regulation of a neighboring oppositely arranged gene is a common feature of TetR-family regulators ([@B1]; [@B54]). Results from EMSAs showed that SbbR only formed complexes with P*~milR~* and P*~R-A~* in a concentration-dependent manner (**Figures [3C,D](#F3){ref-type="fig"}**), while 500-fold excess of non-specific poly (dI-dC) could not dissociate SbbR from P*~milR~* (DNA region upstream of *milR*) or P*~R-A~* (Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}). Negative control P*~hrdB~* also showed no band-shift when SbbR concentration reaches 0.4 μM (**Figure [3E](#F3){ref-type="fig"}**). These results suggested that SbbR binds specifically to P*~milR~* and P*~R-A~*.

![Binding of purified SbbR to the promoter regions of *milR*, *sbbR*, and *sbbA.* **(A)** Schematic representation of the relative positions of *sbbR*, *sbbA*, and the *mil* cluster. The vertical arrows indicate the binding region of SbbR. **(B)** SDS-PAGE analysis of the purified SbbR-His~6~ (23.6 kDa). **(C--E)** EMSAs of SbbR binding to the promoters P*~milR~*, P*~R-A~*, and P*~hrdB~*. P*~milR~*: the promoter region of *milR*. P*~R-A~*: the intergenic region of *sbbR* and *sbbA*. P*~hrdB~*: the promoter region of *hrdB*. Each lane contains 10 ng of DNA probes. The promoter regions of *milR*, the bidirectional *sbbR*/*sbbA* and *hrdB* were prepared as 413, 464, and 443 bp probes, respectively. DNA-protein complexes and free probes are indicated by arrows.](fmicb-09-01064-g003){#F3}

To further define the accurate binding sequences of SbbR in the upstream region of *milR* and the intergenic region of *sbbR*-*sbbA*, the transcription start points (tsps) of *milR*, *sbbR*, and *sbbA* were determined by 5′ RACE. For *milR*, the tsp was identified at a C, 39 nt upstream of the *milR* translation start codon (tsc) (Supplementary Figure [S4A](#SM1){ref-type="supplementary-material"}). For *sbbR*, the tsp was identified at a C, 15 nt upstream of the *sbbR* tsc (Supplementary Figure [S4B](#SM1){ref-type="supplementary-material"}). For *sbbA*, the tsp was identified at a G, 43 nt upstream of the *sbbA* tsc (Supplementary Figure [S4C](#SM1){ref-type="supplementary-material"}). DNase I footprinting experiments with 5′ FAM labeled probes were carried out to define the protected sites of SbbR on its target promoters. As shown in **Figure [4](#F4){ref-type="fig"}**, SbbR protected a region spanning from nt -279 to -252 relative to the *milR* tsp (**Figures [4A,C](#F4){ref-type="fig"}**), far away from the -35 and -10 elements of *milR* promoter. The footprint of the *sbbR* promoter region covered a region from nt -106 to -71 (**Figures [4B,D](#F4){ref-type="fig"}**), and this region corresponds to positions -30 to +5 relative to the tsp of *sbbA* (**Figures [4B,E](#F4){ref-type="fig"}**). Analysis of these two protected sequences interacting with SbbR showed no consensus motif. However, after careful examination, a 6 nt imperfect inverted repeat (CCGAYG \[Y=C or T\]) with 8 bp spacing within the binding region of SbbR on P*~milR~*, and another different 6 nt inverted repeat (CCATHA \[H=C or A\]) with 11 bp spacing within the protected sequences of SbbR on P*~R-A~* were defined, respectively.

![Binding sequences of SbbR on the promoter regions of *milR*, *sbbR*, and *sbbA*. **(A)** DNase I footprinting assay of SbbR binding site on *milR* promoter region (P*~milR~*). **(B)** DNase I footprinting assay of SbbR binding site on *sbbR* (*sbbA*) promoter region P*~R-A~*. Upper fluorograms: control reaction with 10 μM BSA. Protection fluorograms were obtained with increasing amounts of SbbR-His~6~. **(C--E)** Nucleotide sequences of the promoter regions of *milR*, *sbbR*, and *sbbA.* The tsp is marked by a bent arrow. The SbbR-binding sequences are underlined, and the putative --10 and --35 regions are marked by boxes. Numbers indicate distance (nt) from respective tsp.](fmicb-09-01064-g004){#F4}

To determine the actual contributions of these two different inverted repeats to the binding activity of SbbR. P*~milR~* and P*~R-A~* were separately mutated to P*~milR~*^∗^ and P*~R-A~*^∗^. To obtain P*~milR~*^∗^, the 6 nt imperfect inverted repeat of P*~milR~* was replaced by *Eco*RI and *Spe*I restriction sites (**Figure [5A](#F5){ref-type="fig"}**); similarly, the 6 nt imperfect inverted repeat of P*~R-A~* was also replaced by *Eco*RI and *Spe*I restriction sites, generating P*~R-A~*^∗^ (**Figure [5C](#F5){ref-type="fig"}**). P*~milR~*^∗^ and P*~R-A~*^∗^ were then tested in EMSAs with SbbR. As shown in **Figure [5](#F5){ref-type="fig"}**, compared with the wild-type DNA probes, only a small amounts of complexes were formed for P*~milR~*^∗^ or P*~R-A~*^∗^ (**Figures [5B,D](#F5){ref-type="fig"}**). Thus, these two inverted repeats were critical in the binding of SbbR.

![Mutational analysis of SbbR binding sites on P*~milR~* and P*~R-A~*. **(A)** Mutations introduced into the 6 nt inverted repeat of P*~milR~*. The changed nucleotides are underlined. **(B)** EMSAs of the wild-type probe P*~milR~* and mutated probe P*~milR~*^∗^. Each lane contains 10 ng of DNA probes. The concentrations of SbbR used in lanes 1 to 4 were 0, 0.1, 0.2, and 0.2 μM, respectively. Line 4 contains 500-fold poly(dI-dC). **(C)** Mutations introduced into the 6 nt inverted repeat of P*~R-A~*. The changed nucleotides are underlined. **(D)** EMSAs of the wild-type probe P*~R-A~* and mutated probe P*~R-A~*^∗^.](fmicb-09-01064-g005){#F5}

*SbbR* Activates the Transcription of *milR* but Represses *sbbR* and *sbbA*
----------------------------------------------------------------------------

To examine the effect of SbbR on the transcription of its targets, RNA samples were extracted from the mycelia of BC04 and ΔsbbR cultivated for various days (1, 2, 3, 5, and 9 days). The transcription levels of *milR*, *sbbR* (the ORF of *sbbR* in ΔsbbR was partially left at its 5′ end) and *sbbA* were then assessed by quantitative real-time RT-PCR (qRT-PCR). The results showed that transcription of *milR* decreased significantly in ΔsbbR at all tested time points, whereas the transcript levels of *sbbR* and *sbbA* were shown to be higher in ΔsbbR than in BC04 (**Figure [6](#F6){ref-type="fig"}**). The transcription profiles of *sbbR* and *sbbA* were similar, reached the highest level at about 3 days of cultivation when milbemycin production was initiated, and then the transcripts decreased gradually (**Figure [6](#F6){ref-type="fig"}**). Since *milA3* is located in the same operon with *milR* (the *milR-A3* operon), and MilR activates the expression of the *milA4-E* operon and *milF* directly ([@B57]); thus, transcription of *milA3*, *milA4*, and *milF* was also measured. Transcripts of these three genes were also decreased dramatically (**Figure [6](#F6){ref-type="fig"}**). These results suggested that SbbR regulates milbemycin biosynthesis by activating the transcription of *milR* directly, and SbbR is a direct repressor of its own transcription and that of *sbbA*.

![Quantitative real-time RT-PCR analysis of *milR*, *sbbR*, *sbbA*, *milA3*, *milA4*, and *milF* in BC04 and ΔsbbR. All RNA samples were isolated from 1, 2, 3, 5, and 9 days cultures. The transcriptional levels of related genes are presented relative to that of BC04 collected after fermentation for 24 h, which was arbitrarily assigned a value of 1. Data are presented as the averages of three independent experiments conducted in triplicate. 16S rRNA transcription was monitored and used as the internal control. Error bars show standard deviations. *P-*values were determined by Student's *t-*test. ^∗^*P* \< 0.05.](fmicb-09-01064-g006){#F6}

The regulatory relationships between SbbR and its target genes (*milR* and *sbbA*) were further verified using a heterologous promoter-reporter system in *Escherichia coli* ([@B51]). As shown in **Figure [7A](#F7){ref-type="fig"}**, the promoters of *milR* and *sbbA* were cloned separately upstream of *gfp* \[encoding green fluorescent protein (GFP)\] to generate pSET152::P*~milR~gfp* and pSET152::P*~sbbA~gfp*, respectively. The resulting plasmids were then each transferred to *E. coli*. Afterwards, *sbbR* controlled by SF14 was assembled into the above two recombinant vectors to generate pSET152::P*~milR~gfp*::SF14*sbbR* and pSET152::P*~sbbA~gfp*::SF14*sbbR*, respectively, which were also introduced into *E. coli*. Then the four strains constructed above together with the control strain harboring pSET152 were detected for green fluorescence. Fluorescence in the strain harboring pSET152::P*~milR~gfp*::SF14*sbbR* was enhanced 2.4-fold compared to that in the strain harboring pSET152::P*~milR~gfp*, while fluorescence in pSET152::P*~sbbA~gfp*::SF14*sbbR*-containing strain exhibited a decrease of 87% compared to that of pSET152::P*~sbbA~gfp* strain (**Figure [7B](#F7){ref-type="fig"}**). These results agreed with the data obtained from transcriptional profiles in *S. bingchenggensis* BC04, and provided convincing evidence that SbbR activates the expression of *milR* and represses the transcription of *sbbA* directly.

![Analyses of regulatory relationships between SbbR and its target genes (*milR* and *sbbA*) in *E. coli*. **(A)** An illustration of the reporter plasmids. **(B)** Determination of the regulatory relationships between SbbR and its target promoters (P*~milR~* and P*~sbbA~*). All values are in relative fluorescence unit (GFP/OD~600~) and represent the averages of at least three independent readings.](fmicb-09-01064-g007){#F7}

Identification of New *SbbR* Targets That Encode Transcriptional Regulatory Proteins
------------------------------------------------------------------------------------

When analyzing the function of SbbR/SbbA system, it is possible that SbbR/SbbA may be involved in a more comprehensive regulation of diverse cellular processes directly or via regulatory cascades. As shown in **Figures [3](#F3){ref-type="fig"}, [4](#F1){ref-type="fig"}**, the promoter of *milR* and the intergenic region of *sbbR* and *sbbA* were the primary targets of SbbR; however, no highly conserved recognition sequence could be extracted from the two binding sites. The relatively unconserved binding sites for SbbR make it difficult to predict novel targets through *in silico* screening of the *S. bingchenggensis* genome sequence using MAST/MEME tool. Therefore, to further explore the SbbR/SbbA regulon, we selectively searched for binding targets of SbbR that encode transcriptional regulators. A total of 43 genes located in putative secondary metabolism clusters and 29 genes that encodes homologs of global or pleiotropic regulators were selected for EMSAs (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). The probes containing the upstream regions of the 72 genes were amplified (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Subsequent EMSAs showed that SbbR has strong affinity for 11 DNA probes (**Figure [8](#F8){ref-type="fig"}**), and the deduced products of the putative target genes were as follows: two SARP family CSRs (SBI_08420 and SBI_08432) of nanchangmycin biosynthetic gene cluster ([@B48]), one SARP family CSR (SBI_09158) of actagardine biosynthetic gene cluster ([@B48]), one LAL family CSR (SBI_00827) of a cluster encoding non-ribosomal peptide synthases ([@B48]), one LAL family CSR (SBI_01376) of lasalocid biosynthetic gene cluster ([@B48]), one putative LAL family regulator (SBI_09325) of melanin biosynthetic gene cluster ([@B48]), one putative Sig24 homologous regulator (SBI_06451, Sig24~sbh~) of desferrioxamine biosynthetic gene cluster ([@B48]), one GlnR homolog (SBI_05051, GlnR~sbh~), one WblA-like protein (SBI_05811, WblA~sbh~), one AtrA homolog protein (SBI_05779, AtrA~sbh~), and one MtrA/B-type two-component system (TCS: SBI_06494/06495, MtrA/B~sbh~).

![Electrophoresis mobility shift assays (EMSAs) of SbbR binding to the upstream regions of 11 novel targets. The amounts of SbbR (μM) used were as indicated and 10 ng of DNA probes was added to each EMSA reaction. Lane 2--4 contains 0.1, 0.2, and 0.2 μM SbbR and Line 4 contains 500-fold non-specific poly (dI-dC).](fmicb-09-01064-g008){#F8}

To investigate the regulatory role of SbbR in the transcription of these new target genes, qRT-PCR analysis was carried out to assess the transcription of related genes. As shown in **Figure [9](#F9){ref-type="fig"}**, SbbR repressed the transcription of two SARP-family regulatory genes (*sbi_08432* and *sbi_09158*) and one LAL-family regulatory gene *sbi_09325*, as the transcriptional levels of these genes were increased in ΔsbbR compared with BC04 at day 3 or both days (days 3 and 5). In contrast, transcription of the other eight genes was lower in ΔsbbR than in BC04 at day 5 or both days, indicating that SbbR is an activator of these genes (**Figure [9](#F9){ref-type="fig"}**). These data suggested that SbbR plays a differential regulatory role toward different target genes. It should be noted that these 11 novel targets of SbbR are identified only from the above 72 transcriptional regulatory genes that act as putative CSRs or pleiotropic regulators. Genome-wide identification of SbbR targets via chromatin immunoprecipitation followed by sequencing (Chip-seq) will be carried out in our future works.

![Quantitative real-time PCR (qRT-PCR) analysis examining the effects of *sbbR* deletion on the transcription of new SbbR target genes. RNA samples were isolated from 3 and 5 days cultures. The transcription of genes in BC04 was assigned a value of 1. 16S rRNA transcription was monitored and used as the internal control. Data are presented as the averages of three independent experiments conducted in triplicate. Error bars show standard deviations. ^∗^*P* \< 0.05.](fmicb-09-01064-g009){#F9}

Effect of Culture Extracts From *S. bingchenggensis* on the Binding Activity of SbbR
------------------------------------------------------------------------------------

In *S. bingchenggensis*, SbbR and SbbA constitute the quorum-sensing system, in which SbbR can respond to the likely GBL-type signaling molecules generated by SbbA. Thus, to determine whether SbbR is able to respond to small signaling molecules produced by *S. bingchenggensis*, ethyl acetate extracts of strains BC04 and ΔsbbA were prepared and assayed for their effect on the binding activity of SbbR to P*~milR~*. As expected, extracts from BC04 could dissociate SbbR from SbbR-P*~milR~* complexes, leading to about forty thousand inhibitory units/l (1 inhibitory units is defined as the activity of dissociating about half of 10 ng of P*~milR~* from SbbR) (Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}). Unexpectedly, when added at a high concentration, extracts from ΔsbbA could also dissociate SbbR from SbbR-P*~milR~* complexes (Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}). This indicated that SbbR could bind the factor determined by the GBL biosynthesis protein SbbA; it could also bind to some unknown ligands produced in ΔsbbA. It is interesting to probe the putative chemicals that bind to SbbR produced by ΔsbbA, which will be the focus of our future work. These results suggested that SbbR may be a genuine signaling molecular receptor protein, and it is possible that the molecules produced by SbbA regulate the biosynthesis of milbemycin via interactions with SbbR, but the further structural analysis is impeded by the fact that they are normally produced in very small quantities ([@B27]).

Discussion
==========

In the Gram-positive *Streptomyces*, ArpA/AfsA systems are important for antibiotic production and morphological differentiation ([@B40]; [@B59]). In the present study, genome analysis of sequenced *S. bingchenggensis* revealed a potential ArpA/AfsA-type system annotated as SbbR/SbbA. *sbbR* and *sbbA* are adjacent and divergently transcribed, but they locate far from the *mil* cluster. We demonstrate that SbbR, a GBL receptor homolog, activates the biosynthesis of milbemycin by directly activating the transcription of *milR*, the CSR of the *mil* cluster; while the GBL synthase homolog, SbbA, has a repressive effect on milbemycin production. Interestingly, both SbbR and SbbA have positive effects on cell growth, and SbbR also acts pleiotropically by controlling the expression of many other CSR genes and global regulatory genes.

Generally, it is thought that GBLs produced by the AfsA homologs are essential for antibiotic production, and mutation of the corresponding homologous genes lead to impaired or reduced production of the respective antibiotics, while disruption of the cognate receptor genes leads to the opposite or no effect ([@B36]; [@B59]). For example, in *S. hygroscopicus* 5008, inactivation of *afsA* homologs (*shbA1*, *shbA2*, or *shbA3*) dramatically decreased biosynthesis of validamycin; whereas deletion of *arpA* homologs (*shbR1* or *shbR3*) increased validamycin production by 26% (ΔshbR1) and 20% (ΔshbR3), and deletion of *shbR2* had no significant effects on validamycin production ([@B41]). However, in *S. bingchenggensis*, the SbbR/SbbA system presented an opposite regulatory pattern: inactivation of the GBL synthase gene (*sbbA*) led to an increase of antibiotic production instead of the anticipated reduction or abolishment, while mutation of *sbbR* resulted in reduced milbemycin production. Virtually, titer improvement of milbemycin in *sbbA* mutant strain is not surprising. In *S. bingchenggensis* BC04, SbbR activates *milR* expression by binding to the upstream region of *milR*; expressed *milR* can activate the transcription of biosynthetic structural genes *milA4-E* and *milF*. The putative compound produced by SbbA could directly bind to SbbR, leading to its dissociation from the *milR* promoter. In ΔsbbA, production of the compound might be abolished, and SbbR could bind *milR* promoter persistently and activates its expression, thus leading to an increased milbemycin production. Previously, titer improvements of antibiotic in GBL synthase gene deficiency strains have been reported. In the model strain *S. coelicolor*, deletion of *scbA*, a homolog of *afsA*, led to overproduction of actinorhodin and undecylprodigiosins ([@B37]; [@B21]). In *S. lividans*, deletion of *scbA* also improved the titers of actinorhodin and undecylprodigiosins ([@B5]). The mechanisms underlying the role of ScbA in increasing actinorhodin and undecylprodigiosins production in these two strains are unclear, but are supposed to be the molecular events that are closely related with the complex regulatory cascade mediated by GBLs. In this work, inactivation of *sbbA* obviously improved the production of milbemycin by 25% (from 2537 to 3169 mg/l); thus the *sbbA* mutant can be used as a new parental strain in the future genetic engineering to obtain milbemycin high-producing strains.

In this work, SbbR played differential regulatory roles toward its targets: it represses the expression of its own gene and the divergently transcribed *sbbA*, but positively regulates milbemycin biosynthesis by directly activating the transcription of *milR*. The promoter sites covered by SbbR were from nt -106 to -71, nt -30 to +5, and nt -279 to -252 relative to the tsps of *sbbR*, *sbbA*, and *milR*. The auto-repression of SbbR on its own is a common feature exerted by TetR family regulators ([@B1]). The mechanism whereby SbbR represses *sbbA* is easy to understand, the protected site overlaps the -35 and -10 elements, SbbR may sterically block the access of RNA polymerase to *sbbA* promoter. While as an activator of *milR*, SbbR locates far upstream of the -35 element and may recruit RNA polymerase to the promoter via direct protein--protein interaction ([@B31]). GBL receptor homologs that bind (far) upstream of promoter region and act as the direct activator of antibiotic CSRs have been reported previously. For instance, in jadomycin biosynthesis in *S. venezuelae*, the GBL (SVB1) receptor, JadR3, can activate the expression of *jadR1*, the cluster-situated activator of jadomycin biosynthesis. JadR3 has three binding sites in the promoter of *jadR1*. Among these sites, AREII, a region from nt -252 to -219 relative to the *jadR1* tsp, is essential for the activation function of JadR3 ([@B59]). In *S. ansochromogenes*, SabR binds to the sequences (from nt -64 to -29 relative to the tsp of *sanG*) adjacent to or overlapping partially with the -35 element and positively regulates *sanG* transcription ([@B10]). There are also exceptions, AvaR1, the ArpA homolog from *S. avermitilis*, protects two regions (regions from nt -262 to -233 and nt -223 to -193) far upstream of AveR (the cluster-situated activator of avermectins) and acts as a repressor, but not an activator ([@B58]); one of the two binding sites (nt -222 to -244 and nt -3 to -35 relative to the *cpkO* tsp) of ScbR from *S. coelicolor* is also far away from *cpkO* promoter and ScbR is a repressor of *cpkO* ([@B38]). These examples complicate the regulatory mechanisms exerted by GBL receptor homologs. Nevertheless, our study and the observations reported previously lead to the conclusion that, in addition to being a repressor of its own expression and that of other targets, GBL receptor homologs could also interact with the upstream regions of cluster-situated activator genes to promote gene expression, suggesting that a GBL receptor homolog-mediated activation of antibiotic biosynthesis might exist in many streptomycetes.

In the search of SbbR/SbbA regulon, 11 genes that encode seven putative secondary metabolism CSRs and four well-known pleiotropic regulatory homologs have been identified. Of these novel targets, the SARP-family regulators (SBI_08420, SBI_08432, and SBI_09158), the LAL-family regulators (SBI_00827, SBI_01376, and SBI_09325) and Sig24~sbh~ are the potential cluster-situated activators, e.g., SBI_08420, designated as NanR2, has recently been reported to be an essential activator of nanchangmycin production ([@B53]), suggesting the importance of SbbR/SbbA in the regulation of secondary metabolism. Moreover, homologs of the four pleiotropic regulators GlnR~sbh~, WblA~sbh~, AtrA~sbh~, and MtrA/B~sbh~ have been reported to be involved in the development of *Streptomyces* as well as in the production of various antibiotics in streptomycetes ([@B30]; [@B20]). Many detailed studies concerning the downstream regulatory networks of these four regulators have been reported ([@B23]), but little is known about the regulatory proteins that function upstream of these pleiotropic regulators, although AdpA~ch~ from *Streptomyces chattanoogensis* L10 has been confirmed to be a direct activator of *wblA~ch~* ([@B52]), and AdpA homolog from *Streptomyces roseosporus* directly regulate the *atrA* homolog ([@B24]). Our finding provides an interesting clue that SbbR, as a GBL receptor homolog, could be a direct controller of these important regulators that act pleiotropically in *Streptomyces*. The molecular regulatory mechanism of SbbR as the upper regulator of these pleiotropic regulators needs further investigation.

SbbR could regulate *milR* directly, however, it is doubted that this is the only regulatory pattern that is exerted by SbbR/SbbA system to regulate milbemycin production. Note that both deletion of *sbbR* and *sbbA* decreased cell biomass in fermentation medium, suggesting the importance of *sbbR* and *sbbA* in cell growth (**Figure [2D](#F2){ref-type="fig"}**); moreover, SbbR has positive effects on the four well-known pleiotropic regulators (i.e., GlnR~sbh~, WblA~sbh~, AtrA~sbh~, and MtrA/B~sbh~). Therefore, it is possible that SbbR/SbbA system may exert pleiotropic effects on primary and secondary metabolism, and the changes of milbemycin production in ΔsbbR and ΔsbbA is not only due to the changed expression levels of biosynthetic genes, but also the changed supplies of precursors and cofactors. Further studies are required to investigate the regulatory targets of SbbR/SbbA system through comparative transcriptomic analysis among BC04, ΔsbbR, and ΔsbbA, and Chip-seq of SbbR, and thereby gain a more comprehensive overview of the roles of SbbR/SbbA system.
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